The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes
Abstract
OBJECTIVE: This study was conducted to update national estimates of the economic burden of undiagnosed diabetes, prediabetes, and gestational diabetes mellitus (GDM) in the United States for year 2017 and provide state-level estimates. Combined with published estimates for diagnosed diabetes, these updated statistics provide a detailed picture of the economic costs associated with elevated blood glucose levels. RESEARCH DESIGN AND METHODS: This study estimated medical expenditures exceeding levels occurring in the absence of diabetes or prediabetes and the indirect economic burden associated with reduced labor force participation and productivity. Data sources analyzed included Optum medical claims for ∼5.8 million commercially insured patients continuously enrolled from 2013 to 2015, Medicare Standard Analytical Files containing medical claims for ∼2.8 million Medicare patients in 2014, and the 2014 Nationwide Inpatient Sample containing ∼7.1 million discharge records. Other data sources were the U.S. Census Bureau, Centers for Disease Control and Prevention, and Centers for Medicare & Medicaid Services. RESULTS: The economic burden associated with diagnosed diabetes (all ages), undiagnosed diabetes and prediabetes (adults), and GDM (mothers and newborns) reached nearly $404 billion in 2017, consisting of $327.2 billion for diagnosed diabetes, $31.7 billion for undiagnosed diabetes, $43.4 billion for prediabetes, and nearly $1.6 billion for GDM. Combined, this amounted to an economic burden of $1,240 for each American in 2017. Annual burden per case averaged $13,240 for diagnosed diabetes, $5,800 for GDM, $4,250 for undiagnosed diabetes, and $500 for prediabetes. CONCLUSIONS: Updated statistics underscore the importance of reducing the burden of prediabetes and diabetes through better detection, prevention, and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Economic Costs of Diabetes in the U.S. in 2017
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dci18-0007 · Cited by 2,528
Dall, T. M., Yang, W., Halder, P., Pang, B., Massoudi, M., Wintfeld, N., Semilla, A. P., Franz, J., & Hogan, P. F. (2014) · Diabetes Care · doi:10.2337/dc14-1036 · Cited by 382
Self-citationHealth and Productivity as a Business Strategy: A Multiemployer Study
Loeppke, R., Taitel, M., Haufle, V., Parry, T., Kessler, R. C., & Jinnett, K. (2009) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e3181a39180 · Cited by 352
The Economic Burden Of Diabetes
Dall, T. M., Zhang, Y., Chen, Y. J., Quick, W. W., Yang, W. G., & Fogli, J. (2010) · Health Affairs · doi:10.1377/hlthaff.2009.0155 · Cited by 319
Self-citationMeasuring Health-Related Productivity Loss
Mitchell, R. J., & Bates, P. (2011) · Population Health Management · doi:10.1089/pop.2010.0014 · Cited by 221
Burden of Diabetes on the Ability to Work
Breton, M.-C., Guénette, L., Amiche, M. A., Kayibanda, J.-F., Grégoire, J.-P., & Moisan, J. (2013) · Diabetes Care · doi:10.2337/dc12-0354 · Cited by 185
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s003 · Cited by 162
Estimating population attributable fractions to quantify the health burden of obesity
Flegal, K. M., Panagiotou, O. A., & Graubard, B. I. (2015) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.11.010 · Cited by 148
Cost of Gestational Diabetes Mellitus in the United States in 2007
Chen, Y., Quick, W. W., Yang, W., Zhang, Y., Baldwin, A., Moran, J., Moore, V., Sahai, N., & Dall, T. M. (2009) · Population Health Management · doi:10.1089/pop.2009.12303 · Cited by 122
Self-citationAsay, G. R. B., Roy, K., Lang, J. E., Payne, R. L., & Howard, D. H. (2016) · Preventing Chronic Disease · doi:10.5888/pcd13.150503 · Cited by 117
Cited by
(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029
Cusi, K., Orsak, B., Bril, F., Lomonaco, R., Hecht, J., Ortiz-Lopez, C., Tio, F., Hardies, J., Darland, C., Musi, N., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1774 · Cited by 1,024
Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications
Bhupathiraju, S. N., & Hu, F. B. (2016) · Circulation Research · doi:10.1161/circresaha.115.306825 · Cited by 945
Economic Costs of Diabetes in the U.S. in 2022
(2023) · doi:10.2337/dci23-0085 · Cited by 808
Polonsky, W., & Henry, R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106821 · Cited by 784
Metadata
- Authors
- Dall, T. M., Yang, W., Gillespie, K., Mocarski, M., Byrne, E., Cintina, I., Beronja, K., Semilla, A. P., Iacobucci, W., & Hogan, P. F.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2019-04-02
- Volume
- 42
- Issue
- 9
- Pages
- 1661-1668
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4247910510
- Cited by
- 438
- References
- 21
- FWCI
- 35.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Novo Nordisk
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes. https://app.cochat.ai/papers/10.2337/dc18-1226
- The paper
- Dall, T. M., Yang, W., Gillespie, K., Mocarski, M., Byrne, E., Cintina, I., Beronja, K., Semilla, A. P., Iacobucci, W., & Hogan, P. F. (2019). The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes. Diabetes Care. https://doi.org/10.2337/dc18-1226
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.